EUCTR2015-002234-53-DK进行中（未招募）1 期
Early administration of anti-latency reversing therapy and broadly neutralizing antibodies to limit the establishment of the HIV-1 reservoir during initiation of antiretroviral treatment - a randomized controlled trial(eCLEAR) - eCLEAR
Department of Infectious Diseases, Aarhus University Hospital0 个研究点目标入组 60 人开始时间: 2016年7月27日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •-No current or prior antiretroviral therapy
- •-Age >18 years
- •-CD4+ T-cell count >200/µL on last visit prior to study entry
- •-Able to give informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 60
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •-Current immunosuppressive therapy
- •-Ongoing AIDS-defining condition
- •-Pregnancy as determined by a positive urine beta-hCG (if female).
- •-Participant unwilling to use reliable contraception methods for the duration of the trial. Reliable methods of birth control include: pharmacologic contraceptives including oral, parenteral, and transcutaneous delivery; condoms with spermicide; diaphragm with spermicide; surgical sterilization; vaginal ring; intrauterine device; abstinence; and post-menopause (if female).
- •-Currently breast-feeding (if female).
- •-Any medical, psychiatric, social, or occupational condition or other responsibility that, in the judgment of the Principal Investigator (PI), would interfere with the evaluation of study objectives (such as severe alcohol abuse, severe drug abuse, dementia).
- •-Hepatitis B or C infection as indicated by the presence of Hepatitis B surface antigen (HBsAg) or hepatitis C virus RNA (HCV-RNA) in blood
- •-Unable to follow protocol regimen
研究者
相似试验
进行中（未招募）
1 期
Early administration of anti-latency reversing therapy and broadly neutralizing antibodies to limit the establishment of the HIV-1 reservoir during initiation of antiretroviral treatment - a randomized controlled trial – eCLEARHIV persistence during initiation of antiretroviral therapyMedDRA version: 20.1 Level: LLT Classification code 10073675 Term: HIV infection CDC category unspecified System Organ Class: 100000004862EUCTR2015-002234-53-GBDepartment of Infectious Diseases, Aarhus University Hospital60
已完成
不适用
Early pharmacological intervention to prevent delirium: HAlopeRidol PrOphylaxis in Older emergency department patieNts. The HARPOON studyacute state of confusiondelier10012221DeliriumNL-OMON39657Vrije Universiteit Medisch Centrum780
进行中（未招募）
不适用
An early treatment with haloperiodl to prevent acute confusion in older patients who are acutely admitted to the hospital.DeliriumEUCTR2011-004762-15-NLVU Univeristy Medical Centre
进行中（未招募）
不适用
Investigation into the possibilities of finding antidotes for the new oral anti blood clotting agentsblood coagulation disordersMedDRA version: 14.1Level: HLTClassification code 10009728Term: Coagulation and bleeding analysesSystem Organ Class: 100000004848EUCTR2013-000474-30-ATMedizinische Universität Innsbruck / Univ.-Klinik für Allg. u. Chirurg. Intensivmedizin
进行中（未招募）
不适用
utritional intervention through a digital game based on the Food Guide for the Brazilian Population aimed at adolescents of the Federal Districtoncommunicable DiseasesOverweightC23.550.291.500.750C23.888.144.699RBR-72zvxvniversidade de Brasília